Dr. Tomas Richardson-Sanchez obtained his PhD in Pharmacology under the supervision of Prof. Rachel Codd at the University of Sydney, Australia. He is currently a Postdoctoral Research Fellow in the labs of Prof. Michael Murphy and Prof. Erin Gaynor at the University of British Columbia.
Dr. Richardson-Sanchez’s research integrates molecular biology, microbial genetics, structural biology, and drug design as approaches towards developing a targeted antimicrobial strategy against the bacterium Campylobacter jejuni. C. jejuni causes a debilitating diarrheal disease in humans which can be lethal in very young, old, or immunocompromised individuals. The disease has a high socioeconomic burden, made worse by lack of a vaccine and increasing frequency of infections that are resistant to treatment by current antibiotics. Dr. Richardson-Sanchez is investigating an iron uptake system used by C. jejuni to thrive and cause disease in humans. Better understanding the components of this iron uptake system could inform antimicrobial strategies and hence reduce the morbidity and mortality associated with this pathogen.
For an up-to-date list of publications by Dr. Richardson-Sanchez, please see ResearchGate.